Workshop/Symposium
Amie Goodin, PhD, MPP
Assistant Professor
University of Florida, United States
Vicki Osborne, PhD (she/her/hers)
Associate Director, Pharmacoepidemiology
GW Pharmaceuticals, part of Jazz Pharmaceuticals
Cambridge, United Kingdom
Deborah Layton, PhD, FISPE
Director
PEPI Consultancy Limited
Southampton, United Kingdom
Daniela C. Moga, MD, PhD (she/her/hers)
Associate Professor
Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
Lexington, United States
Almut G. Winterstein, PhD
Distinguished Professor
University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
Gainesville, United States
Catherine Cohet, PhD (she/her/hers)
Pharmacoepidemiology/RWE Senior Specialist
European Medicines Agency
Amsterdam, Netherlands
Lisa G. Pont, PhD
Professor of Pharmacy
Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia, Australia
David Moeny, MPH (he/him/his)
Acting Deputy Director, Office of Pharmacovigilance and Epidemiology
U.S. Food and Drug Administration
Silver Spring, United States
Olaf H. Klungel, PharmD, PhD
Professor
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Utrecht, Netherlands
Simone P. Pinheiro, ScD MSc
Head, PECOE/global epi
AbbVie
North Chicago, United States
John D. Seeger, PharmD, DrPH, FISPE
Chief Scientific Officer
Optum Epidemiology
Boston, United States
K. Arnold Chan, MD, ScD, FISPE
Professor
National Taiwan University
Taipei, United States
Joshua D. Brown, PharmD, PhD
Associate Professor
Pfizer, Inc.
Gainesville, United States
Stanley A. Edlavitch, PhD, MA (he/him/his)
Professor
UMKC
Kansas City, United States
Hugh H. Tilson, MD, DrPH
Adjunct Professor
UNC Gillings School of Global Public Health
Chapel Hill, United States